- Home
- BHAT vs PPBT Comparison
BHAT vs PPBT Comparison
Compare BHAT & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- PPBT
- Stock Information
- Founded
- BHAT 2010
- PPBT 2010
- Country
- BHAT China
- PPBT Israel
- Employees
- BHAT N/A
- PPBT N/A
- Industry
- BHAT Recreational Games/Products/Toys
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- PPBT Health Care
- Exchange
- BHAT Nasdaq
- PPBT Nasdaq
- Market Cap
- BHAT 12.3M
- PPBT 2.1M
- IPO Year
- BHAT 2019
- PPBT N/A
- Fundamental
- Price
- BHAT $1.68
- PPBT $0.59
- Analyst Decision
- BHAT
- PPBT Strong Buy
- Analyst Count
- BHAT 0
- PPBT 1
- Target Price
- BHAT N/A
- PPBT $33.00
- AVG Volume (30 Days)
- BHAT 1.1M
- PPBT 2.9M
- Earning Date
- BHAT 04-30-2025
- PPBT 11-14-2025
- Dividend Yield
- BHAT N/A
- PPBT N/A
- EPS Growth
- BHAT N/A
- PPBT N/A
- EPS
- BHAT N/A
- PPBT N/A
- Revenue
- BHAT $18,724,190.00
- PPBT N/A
- Revenue This Year
- BHAT N/A
- PPBT N/A
- Revenue Next Year
- BHAT N/A
- PPBT N/A
- P/E Ratio
- BHAT N/A
- PPBT N/A
- Revenue Growth
- BHAT N/A
- PPBT N/A
- 52 Week Low
- BHAT $1.51
- PPBT $0.53
- 52 Week High
- BHAT $45.00
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- BHAT 47.96
- PPBT 14.63
- Support Level
- BHAT $1.62
- PPBT $0.53
- Resistance Level
- BHAT $1.83
- PPBT $0.63
- Average True Range (ATR)
- BHAT 0.16
- PPBT 0.13
- MACD
- BHAT 0.00
- PPBT -0.03
- Stochastic Oscillator
- BHAT 22.55
- PPBT 3.40
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.